MedTrace Logo

Continuous Glucose Monitoring in Youth With Type 2 Diabetes

NCT02293577 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2020-03-06

No results posted yet for this study

Summary

The purpose of this study is to use a continuous glucose monitor (CGM) to describe the day to day blood glucose variability in youth with type 2 diabetes. The hypothesis is that CGM will identify caloric and exercise related variation in blood glucose that is not identified by the subjects' current regimen of intermittent finger stick blood glucose measurements.

Conditions

Interventions

DEVICE

continuous glucose monitor

In this study all subjects will wear a continuous glucose monitor for 5 days.

Sponsors & Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • Yale University

    lead OTHER

Principal Investigators

  • Michelle Van Name · Yale University

Eligibility

Min Age
10 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02293577 on ClinicalTrials.gov